During the past decade, Southeastern Medical Oncology Center-Jacksonville conducted 132 clinical trials. In the 10-year time frame, 132 clinical trials started and 64 clinical trials were completed, i.e. on average, 48.5% percent of trials that started reached the finish line to date. In the past 5 years, 41 clinical trials started and 56 clinical trials were completed. i.e. 136.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Southeastern Medical Oncology Center-Jacksonville" #1 sponsor was "National Cancer Institute (NCI)" with 76 trials, followed by "SWOG Cancer Research Network" with 35 trials sponsored, "Alliance for Clinical Trials in Oncology" with 27 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 12 trials sponsored and "NRG Oncology" with 12 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Southeastern Medical Oncology Center-Jacksonville" #1 collaborator was "National Cancer Institute (NCI)" with 85 trials as a collaborator, "NRG Oncology" with 13 trials as a collaborator, "Canadian Cancer Trials Group" with 10 trials as a collaborator, "AstraZeneca" with 2 trials as a collaborator and "Novartis" with 2 trials as a collaborator. Other collaborators include 11 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "Southeastern Medical Oncology Center-Jacksonville" are "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Invasive Breast Carcinoma" (7 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials), "Recurrent Breast Carcinoma" (6 trials) and "Stage IV Breast Cancer AJCC v6 and v7" (6 trials). Many other conditions were trialed in "Southeastern Medical Oncology Center-Jacksonville" in a lesser frequency.

Most popular intervention types in "Southeastern Medical Oncology Center-Jacksonville" are "Drug" (139 trials), "Other" (102 trials), "Biological" (67 trials), "Procedure" (46 trials) and "Radiation" (8 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (47 trials), "Quality-of-Life Assessment" (41 trials), "Computed Tomography" (31 trials), "Biospecimen Collection" (25 trials) and "Questionnaire Administration" (25 trials). Other intervention names were less common.

The vast majority of trials in "Southeastern Medical Oncology Center-Jacksonville" are 139 trials for "All" genders, 25 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Southeastern Medical Oncology Center-Jacksonville". undefined are not yet recruiting, 48 are recruiting, 79 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 31 completed trials in Southeastern Medical Oncology Center-Jacksonville, 2 suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Southeastern Medical Oncology Center-Jacksonville, 7 "Phase 1" clinical trials were conducted, 87 "Phase 2" clinical trials and 89 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".